Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 3 medicines
Canada
Health Canada · 1 medicine · Historical list
All medicines with Soybean
Every register, a page at a time. Strengths and packs are on each medicine’s page.
22 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Grain and Seed AntigensCombination | United States | Status unknown | |||
| A-2Combination | United States | Status unknown | |||
| Chip CravingsCombination | United States | Status unknown | |||
| Intralipid 20% | United States | 20% | injectable | Marketed | Fresenius |
| Intralipid 30% | United States | 30% | injectable | Marketed | Fresenius |
| Nutrilipid 20% | United States | 20% | injectable | Marketed | B Braun |
| Soyacal 10% | United States | 10% | injectable | Not marketed | Alpha Thera |
| Soyacal 20% | United States | 20% | injectable | Not marketed | Alpha Thera |
| Intralipid 10% | United States | 10% | injectable | Not marketed | Fresenius |
| Nutrilipid 10% | United States | 10% | injectable | Not marketed | B Braun |
| Liposyn III 10% | United States | 10% | injectable | Not marketed | Hospira |
| Liposyn III 20% | United States | 20% | injectable | Not marketed | Hospira |
| Liposyn III 30% | United States | 30% | injectable | Not marketed | Hospira |
| Travamulsion 10% | United States | 10% | injectable | Not marketed | Baxter Hlthcare |
| Travamulsion 20% | United States | 20% | injectable | Not marketed | Baxter Hlthcare |
| Guna-Virus | United States | Status unknown | |||
| Smoflipid 20%Combination | United States | 3GM/100ML; 6GM/100ML; 5GM/100ML; 6GM/100ML, 3GM/100ML; 6GM/100ML; 5GM/100ML; 6GM/100ML, 3GM/100ML; 6GM/100ML; 5GM/100ML; 6GM/100ML … | emulsion | Marketed | Fresenius Kabi USA |
| Clinolipid 20%Combination | United States | 16%(160GM/1000ML); 4% | emulsion | Marketed | Baxter Hlthcare Corp |
| Kabiven in Plastic ContainerCombination | United States | 3.3%; 29MG/100ML; 9.8GM/100ML; 96MG/100ML; 174MG/100ML; 239MG/100ML; 147MG/100ML; 3.9GM/100ML, 3.3%; 29MG/100ML; 9.8GM/100ML; 96MG/100ML; 174MG/100ML; 239MG/100ML; 147MG/100ML; 3.9GM/100ML, 3.3%; 29MG/100ML; 9.8GM/100ML; 96MG/100ML; 174MG/100ML; 239MG/100ML; 147MG/100ML; 3.9GM/100ML … | emulsion | Marketed | Fresenius Kabi USA |
| Perikabiven in Plastic ContainerCombination | United States | 2.4%; 20MG/100ML; 6.8GM/100ML; 68MG/100ML; 124MG/100ML; 170MG/100ML; 105MG/100ML; 3.5GM/100ML, 2.4%; 20MG/100ML; 6.8GM/100ML; 68MG/100ML; 124MG/100ML; 170MG/100ML; 105MG/100ML; 3.5GM/100ML, 2.4%; 20MG/100ML; 6.8GM/100ML; 68MG/100ML; 124MG/100ML; 170MG/100ML; 105MG/100ML; 3.5GM/100ML | emulsion | Marketed | Fresenius Kabi USA |
| Liposyn II 10%Combination | United States | 5%; 5% | injectable | Not marketed | Hospira |
| Liposyn II 20%Combination | United States | 10%; 10% | injectable | Not marketed | Hospira |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 2
- Medicines
- 4
- Companies
- 1